Cardiff Oncology, Inc.CRDFNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank7
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-46.59M
↓ 47% vs avg
Percentile
P7
Near historical low
Streak
1 yr
Consecutive growthContracting
Average
$-31.80M
Historical baseline
PeriodValueYoY Change
TTM$-46.59M+3.4%
2024$-48.25M-7.2%
2023$-45.01M-13.5%
2022$-39.67M-39.6%
2021$-28.40M-50.8%
2020$-18.84M-18.3%
2019$-15.92M-1.4%
2018$-15.70M+31.2%
2017$-22.82M+37.9%
2016$-36.76M-